Condition
Juvenile Myelomonocytic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Juvenile Myelomonocytic Leukemia clinical trials that are recruiting, at sites in 6 countries (most in United States (7), Germany (1), Australia (1)). By phase: Phase 2 (3), Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 6Countries
Newest Juvenile Myelomonocytic Leukemia clinical trials
All recruiting trials (8)
-
Depleting specific immune cells in stem cell transplants for blood cancers
This study is testing if removing certain immune cells during stem cell transplants can help children and young adults with blood cancers have better outcomes and fewer complications.
-
T cell receptor depletion for blood cancer treatment
This study is testing a new way to treat blood cancers by using a special treatment before a stem cell transplant to see if it helps both kids and adults do better after the procedure.
-
Screening for pediatric leukemia in children with relapsed or difficult-to-treat cases
This study is testing how to better screen children and young adults with tough cases of leukemia to see if they qualify for new treatment options.
-
CIML NK cell infusion for relapsed myeloid disease after stem cell transplant
This trial tests whether giving cytokine‑induced memory‑like (CIML) natural killer cells together with low‑dose IL‑2 can help adults (≥18) and teens (≥12) whose AML, MDS, MPN, or JMML has returned after a stem cell transplant.
-
Using CD45RA Depleted Stem Cells to Improve Immune Recovery After Transplant
This study is testing if using special stem cells can help patients with acute leukemia recover their immune system faster after a transplant and reduce the risk of complications.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
-
Hematopoietic stem cell transplant for blood cancers
This study is testing two different ways of doing stem cell transplants for people with blood cancers to see which method works better and is safer.
-
Epidemiology and characterization of childhood MDS and JMML
This project will test whether a standardized review of cell appearance plus detailed genetic tests helps improve diagnosis and classification for children and adolescents with MDS or JMML.
Related topics
Quick answers
How many Juvenile Myelomonocytic Leukemia clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (7 trials), Germany (1 trial), Australia (1 trial), Canada (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.